Overview of studies demonstrating EV-mediated cell-to-cell communication in the liver in MAFLD
Cell source | Cargo | Target cell | Associated molecules and/or signaling pathways | Role in MAFLD | References |
---|---|---|---|---|---|
Hepatocytes | Not evaluated | KCs | Not evaluated | Pro-inflammatory | [37] |
TRAIL | Bone marrow-derived macrophages (BMDM) and THP-1 macrophages | CHOP-DR5-Caspase-3/Caspase-8-ROCK1NF-κBRIP1 | Promotes M1 polarization of BMDM and THP-1 macrophages | [14] | |
ITGβ1 | THP-1 macrophages | Not evaluated | Promotes THP-1 inflammatory phenotype and increasesTHP-1-LSEC adhesion | [38] | |
Ceramides | Macrophages | IRE1α-XBP1-Sptlc1 and Sptlc2 | Promotes activation and recruitment of macrophages | [11, 39] | |
S1P | Macrophages | SphK1 and SphK2 S1P1 receptor | Promotes activation and recruitment of macrophages | [40] | |
mtDNA | KCs and RAW 264.7 cells | TLR-9 | Promotes activation of KCs and RAW 264.7 cells | [41, 42] | |
HSCs | Proteins | Not evaluated | ECM components, proteasome, collagens, vesicular transport, metabolic enzymes, ribosomes, and chaperones | Regulation of HSC activation and fibrogenic pathways in vivo | [43] |
Fibrogenic proteins | HSCs, macrophages, and endothelial cells (ECs) | PDGF; SHP2; mTOR signaling; ROCK signaling | Autophagy plays a critical role in the release of pro-fibrogenic EVs and HSC function | [44] | |
LSECs | IGFBP7; ADAMTS1 | Fibrotic Th17 cells | Histone deacetylase 2 (HDAC2)DNA methyltransferase 1 (DNMT1) | Epigenetic dysregulation of LSEC exacerbates liver disease | [45] |
Tropomyosin-1 (TPM1) | Rat hepatocytes, HSCs, human macrophages | ESCRT-dependent pathway (Mvb12-a, Mvb12-b), lipid-rafts structures such as Flot2, tetraspanins CD9 and CD81, and the Rab3 small GTPase | Deactivation of HSCs | [46] |
TRAIL: tumor necrosis factor-related apoptosis-inducing ligand; ITGβ1: integrin β1; IGFBP7: insulin-like growth factor-binding protein-7; Th17: T helper type 17; ROCK1: Rho-associated, coiled-coil-containing protein kinase 1; NF-κB: nuclear factor-κB; RIP1: receptor-interacting protein kinase 1; IRE1α: inositol-requiring transmembrane kinase/endoribonuclease 1α; SphK1: sphingosine kinase 1; TLR-9: Toll-like receptor-9; PDGF: platelet-derived growth factor; SHP2: srchomology-2-domain-containing PTP 2; mTOR: mechanistic target of rapamycin; CHOP: C/EBP homologous protein; DR5: death receptor 5; ADAMTS1: ADAM metallopeptidase with thrombospondin type 1 motif 1; XBP1: X-box binding protein 1; Sptlc1: serine palmitoyltransferase long chain base subunit 1; S1P: sphingosine 1-phosphate; Flot2: flotillin 2; Mvb12-a/b: multivesicular body subunit 12A/B